Brief: Nanexa Signs Agreement With European Biotech Company For Evaluation Of PharmaShell
28/01/2021 08:36
Jan 28 (Reuters) - Nanexa AB NANEXA.ST :
* NANEXA SIGNS AGREEMENT WITH A EUROPEAN BIOTECH COMPANY FOR
EVALUATION OF PHARMASHELL®
* SIGNED AN EVALUATION AGREEMENT, A SO-CALLED MATERIAL
TRANSFER
AND FEASIBILITY STUDY AGREEMENT, WITH A NON-DISCLOSED EUROPEAN
BIOTECH COMPANY
Source text for Eikon: ID:nMFNbvlnK
Further company coverage: NANEXA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on Nanexa AB
See all newsNanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology
Brief: Nanexa And Novo Enter Global License, Collaboration Deal
Brief: Forge Nano And Nanexa To Develop Gmp-Compatible Ald Manufacturing Equipment
Brief: Nanexa Q2 Revenue Amounted To SEK 1.7 Million
Sweden's Nanexa Q1 revenue falls, loss widens